Petroleo Brasileiro S/A ADS (PBR) Financials Nov 14, 2014,
Petroleo Brasileiro S/A ADS (PBR) Financials Nov 14, 2014, 7:57 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Petroleo Brasileiro S/A ADS
Fiscal year is January-December. All values BRL millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 182.83B 211.84B 244.18B 281.38B 304.89B
Cost of Goods Sold (COGS) incl. D&A 114.18B 141.11B 172.93B 219.35B 241.27B
COGS excluding D&A 99.61B 126.49B 155.19B 197.58B 212.81B
Depreciation & Amortization Expense 14.57B 14.61B 17.74B 21.77B 28.47B
Depreciation 13.91B 14B - 21.28B 28B
Amortization of Intangibles 663M 613M - 488M 468M
Gross Income 68.65B 70.74B 71.25B 62.03B 63.62B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 16.13B 18.1B 20.04B 21.68B 23.78B
Research & Development 1.36B 1.74B 2.44B 2.24B 2.43B
Other SG&A 14.77B 16.36B 17.6B 19.45B 21.35B
Other Operating Expense 5.92B 6.51B 7.96B 8.92B 10.19B
Unusual Expense 152M 1.9B 838M 1.76B 2.15B
EBIT after Unusual Expense (152M) (1.9B) (838M) (1.76B) (2.15B)
Non Operating Income/Expense (1.98B) 1.77B (3.16B) (4.54B) 151M
Non-Operating Interest Income 1.39B 2.82B 5.5B 5.18B 2.78B
Equity in Affiliates (Pretax) (65M) - - - -
Interest Expense 1.52B 1.49B 785M 2.64B 3.38B
Gross Interest Expense 4.77B 6.75B 8.15B 10.07B 11.88B
Interest Capitalized 3.25B 5.26B 7.36B 7.43B 8.5B
Pretax Income 44.28B 47.32B 43.97B 27.67B 27.06B
Income Tax 10.93B 12.03B 11.24B 6.79B 5.15B
Income Tax - Current Domestic 9.17B 6.24B 5.08B 2.54B 4.83B
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 1.76B 5.78B 6.16B 4.26B 322M
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 585M 386M 84M 1.1B
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 33.34B 35.88B 33.11B 20.96B 23.01B
Minority Interest Expense 3.29B 692M (203M) (223M) (563M)
Net Income 30.05B 35.19B 33.31B 21.18B 23.57B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 30.05B 35.19B 33.31B 21.18B 23.57B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 30.05B 35.19B 33.31B 21.18B 23.57B
EPS (Basic) 3.43 3.57 2.55 1.62 1.81
Basic Shares Outstanding 8.77B 9.87B 13.04B 13.04B 13.04B
EPS (Diluted) 3.43 3.57 2.55 1.62 1.81
Diluted Shares Outstanding 8.77B 9.87B 13.04B 13.04B 13.04B
EBITDA 61.18B 60.74B 60.99B 53.19B 58.12B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Wading into the murky waters of U.S. healthcare insurance isn't for the faint of heart, but Altea's making its move. Backed by MISSION, they're banking on a niche strategy by tapping veteran Justin Rodrick as Vice President. Their tactic? Aim squarely at the under-served segment of small to mid-sized medical and healthcare facilities. The play's bold, and if Rodrick's got...
Continue Reading
Peeking into the Home Care Playbook The process of starting home care isn't some mind-boggling puzzle. For families in Northeastern Pennsylvania, things kick off with a cordial chinwag with a care coordinator—no paperwork chains or Kafkaesque contracts right off the bat. Now, if you've got someone in need of care, this gives you time to shove all your questions onto the...
Continue Reading
The Battle Against Drug Resistance Heats Up Folks, we're in a never-ending fight here against one of the toughest adversaries out there: lung cancer. And lemme tell ya, when drugs show resistance, it's like trying to punch a ghost. But there’s a fresh wind blowing, as Dr. Bobak Parang steps up to the plate with a $620K grant aimed squarely at tackling drug resistance in...
Continue Reading
Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...
Continue Reading
It's a wild world out there for epilepsy treatments—like a relentless bull run with everyone eyeing the prize. The latest buzz points to a fat 2036 forecast for this sector, driven by a mix of standout technologies and breakthrough therapies. You'd be a fool to blink and miss it. Rising Numbers Stir the Market The numbers, oh boy, they're climbing. In 2025, about 7...
Continue Reading
More Than Just a Debt Guru It's not every day you see a former NFL player shifting gears so smoothly into the corporate world, and then to community service like a missile lock. But that's exactly what Don Silvestri, president of Debt.com, has done. Dragging a hefty reputation as a placekicker for teams like the New York Jets and the Buffalo Bills, he's now making...
Continue Reading
Innovation Meets Organ Donation Out of all the business moves you hear about, this one rings loud because it doesn’t just move the needle on a spreadsheet—it moves the needle on life or death. The Center for Organ Recovery & Education (CORE) is stepping into the future with a high-tech touch to enhance their lifesaving mission. Partnering with InVita Healthcare...
Continue Reading
Bringing the Classics to the Digital Frontier Here's what's lighting a fire under the world of high-end furniture: MillerKnoll's got its eye on the prize by jazzing up Knoll.com with shiny new 3D product configurators. It's like taking a century's worth of design stuffiness and spinning it into the future, ready to dazzle a whole new set of eyeballs. Why This Move Matters...
Continue Reading
Transformations in enterprise management are knocking at the door with Dotwork's latest move. Their strategic acquisition of Arcario Group aims to flip the lid on how companies tie strategies to their daily grind using AI. Let me level with you—this ain't about just spicing up some dashboards or workflows. We're talking about an enterprise-level overhaul in the very way...
Continue Reading
Boeing's Rocky Rollercoaster Ride This Quarter Man, if you want a case study on turbulence in the business world, look no further than Boeing's recent third-quarter performance. This juggernaut managed to clock in $24.2 billion in revenues, up 4% from last year, but it still can't seem to shake off its streak of red ink. We're talking a net loss of $116 million, or a GAAP...
Continue Reading
Top 5 Most Recently Viewed Articles
Bitget Joins the Crypto Jazz Festival in Montreux Bitget, a prominent name in the cryptocurrency exchange and Web3 space, is delighted to announce its collaboration as a primary partner for the inaugural Crypto Jazz Festival. Set against the backdrop of the renowned Montreux Jazz Festival, this innovative event is designed to incorporate the world of cryptocurrency with...
Continue Reading
Compass Diversified Sets Date for Q3 2024 Earnings Release Compass Diversified (NYSE: CODI), located in Westport, Connecticut, has officially announced its plans to unveil the financial results for the third quarter that concluded on September 30, 2024. This announcement is scheduled for a release on Wednesday, October 30, 2024, just after market trading concludes. The...
Continue Reading
US Data to Influence Fed Rate Cut Expectations The US dollar shows a complex performance against its major peers, particularly facing challenges only against the Australian dollar. Recently, the Australian dollar has reached levels not seen in 15 months, showcasing a strong upward trajectory. Despite the ups and downs, market analysts suggest that the dollar’s movements...
Continue Reading
Rémy Martin Celebrates Lunar New Year with Art The renowned House of Rémy Martin proudly announces a remarkable collaboration with celebrated Chinese artist Xue Song to honor the Lunar New Year. This year's theme, inspired by the Year of the Horse, sees Xue Song reinterpreting the iconic Centaur figure associated with Rémy Martin, translating its symbolism into a...
Continue Reading
Exciting Upcoming Events for Trulieve Cannabis Corp Trulieve Cannabis Corp (CSE: TRUL, OTCQX: TCNNF) is making waves in the cannabis sector with its recent announcement regarding its participation in various significant events coming up in the near future. Known for being a leading company in the cannabis market, Trulieve continues to solidify its reputation through...
Continue Reading